Eptifibatide and ST Segment Resolution Following Primary PCI

PHASE3TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

March 31, 2011

Conditions
Myocardial Infarction
Interventions
DRUG

eptifibitide

Patients will be randomized to eptifibatide or no eptifibatide. If randomized to eptifibatide: 180 mcg/kg Bolus; 2 mcg/kg/min infusion immediately prior to primary PCI or at the time of PCI and for 18 - 24 hours following the PCI Second 180 mcg/kg Bolus 10 min after the first

Trial Locations (1)

20010

Washington Hospital Center, Washington D.C.

All Listed Sponsors
lead

Medstar Health Research Institute

OTHER